Zemax

Quick links to important sections

Zemax

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zemax

What is Zemax?

Zemax is a pharmaceutical formulation that contains azithromycin, which is a macrolide antibiotic. It is primarily used for the treatment of various bacterial infections. Unlike some other forms of azithromycin, Zemax is typically designed as an extended-release liquid suspension, allowing for a complete course of treatment to be administered in a single dose.

Mechanism of Action

As an antibiotic, the active ingredient in Zemax works by interfering with the way bacteria produce proteins. Specifically, it binds to the 50S subunit of the bacterial ribosome. By inhibiting protein synthesis, the medication prevents bacteria from growing and multiplying, which assists the body's immune system in clearing the infection.

Clinical Applications

Zemax is indicated for the treatment of mild to moderate infections caused by susceptible strains of specific microorganisms. Its use is common in addressing respiratory tract and skin infections, including:

  • Community-acquired pneumonia: Lung infections developed outside of a hospital setting.
  • Acute bacterial exacerbations of chronic bronchitis: Sudden worsening of inflammation in the bronchial tubes.
  • Acute bacterial sinusitis: Infection of the sinuses.
  • Pharyngitis or tonsillitis: Infections of the throat and tonsils, often used as an alternative for individuals who cannot use first-line treatments.
  • Skin and skin structure infections: Uncomplicated bacterial infections of the skin.

Formulation Characteristics

The distinguishing feature of Zemax is its microsphere technology. The active medication is encapsulated in small particles that release the drug slowly as it passes through the digestive system. This design is intended to provide a high concentration of the antibiotic while minimizing common gastrointestinal side effects associated with immediate-release formulations. Because it is an extended-release product, it is not interchangeable with other azithromycin tablets or oral suspensions on a milligram-to-milligram basis.

Regulatory References

  1. MedlinePlus Drug Information on Lisinopril

What side effects are possible with Zemax?

Possible Side Effects and Safety Information

The official safety profile for Lisinopril (Zemax) defines a spectrum of potential adverse reactions, categorized by frequency and the body system affected, strictly based on regulatory documentation.

Adverse Reaction Scope

Classification Examples of Reactions Affected Systems Serious Reactions (Label-Documented)
Common Headache, Dizziness, Cough, Diarrhea, Hypotension Nervous, Respiratory, Gastrointestinal, Vascular Angioedema, Acute Renal Failure, Hepatic Failure
Serious Fetal Toxicity, Anaphylactoid Reactions Cardiovascular, Renal, Immune

Common effects are those reported in official documents with an incidence of one percent or greater, including Cough, which is a recognized adverse effect associated with this class of medication. Hypotension, or low blood pressure, should be anticipated, particularly following the initial exposure in patients who are volume-depleted, as noted in regulatory materials.

Safety Considerations and Restrictions

The label defines specific constraints, including an absolute Contraindication in Pregnancy due to the high risk of fetal toxicity, which can lead to serious adverse effects on the fetus and neonate. Furthermore, the medicine is contraindicated in individuals with a history of Angioedema related to previous treatment with an Angiotensin-Converting Enzyme (ACE) Inhibitor. Safety warnings also address the potential for Hyperkalemia (elevated serum potassium) and specific risks for patients with Impaired Renal Function, with the safety and efficacy not established for pediatric patients under six years of age.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documentation describes overdose of the active ingredient, Lisinopril, primarily as an exaggerated physiological effect leading to severe consequences. The main documented clinical manifestation is Hypotension (severely low blood pressure), which may lead to associated signs like dizziness, lightheadedness, and syncope (fainting).


Documented Severe Outcomes and Required Actions

Classification Official Regulatory Statement
Severe Outcomes Documented severe outcomes include Circulatory shock and Acute renal failure. The risk of complications is increased in patients with pre-existing renal insufficiency if severe hypotension occurs.
Emergency Actions Seek immediate medical attention and contact a Poison Control Center or local emergency services. Immediate help is required if symptoms are severe or life-threatening, such as collapse or loss of consciousness.

Overdose Management

No specific antidote is known for Lisinopril overdose. Treatment is defined as symptomatic and supportive. Supportive measures may involve administering Intravenous fluid (e.g., normal saline solution) to help restore blood pressure. Haemodialysis is listed as an effective procedure to remove the active substance from the circulation. Continuous monitoring of blood pressure, renal function, and serum potassium is required following an overdose.

Therapeutic Uses of Zemax

What Zemax Treats: Main Uses and Benefits

The active ingredient in Zemax is commonly used in the management of a wide range of bacterial infections. It is applied across domains where additional symptomatic support is needed in the context of conditions presenting with acute episodes. Zemax is relevant in clinical settings involving acute or unstable symptom patterns, such as those related to conditions affecting the respiratory tract, ear, and skin.

Key Therapeutic Domains

Zemax is used for managing symptom clusters that may become intense or disruptive and interfere with daily comfort. It is relevant when supportive symptom management is appropriate, helping to ease the overall symptom burden. The medicine assists with maintaining functional stability during episodes of systemic strain and contributes to improved day-to-day comfort. It is considered relevant when short-term symptomatic assistance is appropriate.

“The medicine provides support that helps ease the overall symptom burden during symptomatic periods.”

Quick Fact: Supports Management of Symptoms that Interfere with Daily Functioning

Eligibility and Restrictions for Use

Zemax (Lisinopril) is an ACE inhibitor whose use is governed by strict population eligibility rules outlined in official regulatory documents.

Population Status Eligibility Rule
Contraindicated Patients with a history of angioedema related to any ACE inhibitor, or hereditary/idiopathic angioedema. Use is also prohibited in patients taking a Neprilysin Inhibitor or within 36 hours of stopping one. Women in the second or third trimester of pregnancy must not use this medicine.
Restricted Use Patients with severe renal impairment require caution. Use is restricted for patients who are volume-depleted, have low blood pressure after an acute myocardial infarction, or have aortic or mitral valve stenosis.
Age Eligibility Approved for adults across all labeled uses. Pediatric use is limited to children ge 6 years of age for hypertension only. Use in children <6 years is officially not established.

The drug is also contraindicated in diabetic patients receiving medication that contains Aliskiren. Safety is not established for pediatric patients with a low glomerular filtration rate. Use is not recommended during the first trimester of pregnancy or while breastfeeding. These official regulatory statements define the populations permitted, restricted, or prohibited from using the medicine.

What should I know about interactions with other medicines?

The interaction profile for Zemax (Lisinopril) is clearly defined by government regulatory agencies through several pharmacodynamic patterns and restrictive classifications. The most critical interaction is the contraindication with Sacubitril/Valsartan, which requires a mandatory 36-hour wash-out period between administrations due to the risk of angioedema. Co-administration is also officially prohibited with Aliskiren in patients with diabetes mellitus, and with certain extracorporeal treatments (such as high-flux dialysis).

Zemax is not metabolized by the Cytochrome P450 enzyme system, which simplifies its metabolic interaction profile. However, it does affect the clearance of Lithium, resulting in increased plasma levels and potential toxicity of the latter.

Several agents cause additive pharmacodynamic effects. Combining Zemax with potassium-sparing diuretics or potassium supplements increases the risk of Hyperkalemia (elevated potassium). Nonsteroidal Anti-inflammatory Drugs (NSAIDs) may diminish the drug’s blood pressure-lowering effect and increase the risk of renal function decline. The risk of angioedema is also heightened when Zemax is co-administered with mTOR inhibitors. Lisinopril absorption is not influenced by food. Higher drug exposure is officially documented in both the elderly population and in patients with severe renal impairment due to reduced clearance.

Mechanism of Action

Inhibiting Bacterial Protein Synthesis

Zemax is an inhibitor that acts primarily by binding reversibly to the 23S rRNA of the bacterial 50S ribosomal subunit. This molecular interaction causes the physical occlusion of the peptide exit tunnel, which is necessary for nascent protein chains to emerge. By blocking this essential translocation process, the drug prevents the bacterial cell from synthesizing the proteins required for its growth and division, thus resulting in the restriction of microbial growth and proliferation.

Modulating Host Responses and Localization

Beyond ribosomal inhibition, the drug engages mechanisms that modulate activity within host immune and epithelial cell signaling pathways. It influences host cells to downregulate the production of specific pro-inflammatory mediators like certain cytokines, contributing to a modulation of inflammatory signaling patterns. Furthermore, the drug is readily taken up and concentrated inside phagocytic immune cells. These cells serve as a mobile delivery mechanism, allowing the compound to be transported and localized to deep tissue compartments where it exerts its inhibitory effect on targets, including those that are intracellular.

Dosage and Administration Information

How Zemax (Lisinopril) is Used: Official Administration Guidelines

Zemax, which contains the active ingredient Lisinopril, is administered orally and is generally prescribed for long-term, once-daily use. The official administration protocols define the starting dose and subsequent adjustments based on the specific condition being managed, ensuring adherence to established clinical standards.

Administration Details and Dosage Structure

The medicine is available in several tablet strengths, typically ranging from 2.5 mg to 40 mg, and may also be available as an oral solution. It can be taken at any time of day, with or without food, but maintaining a consistent daily schedule is advised. The dosage structure is not static and requires clinical guidance for initiation and maintenance.


Official Dosing and Use Protocols

The initial dose is specific to the indication. For Hypertension, an initial dose of 10 mg is commonly prescribed, with the usual maintenance dose ranging from 20 mg to 40 mg daily. In contrast, treatment for Heart Failure begins with a lower starting dose, often 2.5 mg or 5 mg once daily. Following the initial phase, doses are adjusted (titrated) gradually over intervals of one to two weeks, as required to reach the appropriate maintenance level.


Population-Specific Use and Special Conditions

Official instructions require dose adjustments for specific patient groups. For example, patients with renal impairment must have a reduced starting dose, with a typical halving of the usual initial dose for moderate impairment. Furthermore, the use of Lisinopril is authorized for pediatric patients geq 6 years with hypertension, following a weight-based dosing schedule. If a daily dose is missed, the general guidance is to omit the dose if the next scheduled time is near and return to the regular schedule; a double dose should not be taken.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Zemax (Lisinopril)

The evidence base for Lisinopril, the active ingredient in Zemax, includes Randomized Controlled Trials (RCTs), systematic reviews, and meta-analyses. This research provides context regarding what has been observed so far in specific patient populations under controlled study conditions. Findings describe group patterns, not personal outcomes, and evidence highlights what is known — and what is still uncertain.


Evidence for Use in High Blood Pressure (Hypertension)

Research examined the use of Lisinopril in both short-term and intermediate-term Randomized Controlled Trials where patients had mild to severe high blood pressure. Across multiple trials, data show patterns related to a change in blood pressure readings in the adult patients studied. Long-term observational studies were evaluated in order to track whether these short-term effects align with outcomes linked to major cardiovascular events. Results apply only to the populations studied. Data for certain groups remain insufficient, particularly when considering the response across diverse racial or ethnic populations.


Evidence for Use in Chronic Heart Failure

Clinical data for chronic heart failure relies on large-scale, long-duration Randomized Controlled Trials (RCTs). In these trials, the active ingredient was studied for its role when used alongside other standard heart failure treatments. Researchers explored primary outcomes such as all-cause mortality and measures of cardiovascular morbidity (e.g., hospitalization rates). Findings describe patterns observed in the studies where patients receiving the active ingredient alongside standard care had observed outcomes related to survival and a rate of hospitalization was observed compared to those receiving standard care plus a placebo. What remains uncertain is the role in patients who have very mild or asymptomatic heart failure.


Evidence Gaps and Areas of Research Uncertainty

While the evidence landscape is robust for the major indications, some research gaps remain. Findings were mixed concerning the magnitude of the change in blood pressure across different demographic groups. There is limited information for long-term outcomes specific to certain special populations, such as children with hypertension. Data are still emerging regarding whether initiating this type of medicine in very early or mild stages of certain conditions has been evaluated for outcomes similar to those seen in more established disease states.

Frequently Asked Questions (FAQ)

Common questions about Zemax (FAQ)

Q: How does Zemax differ from other similar medicines I see advertised?

A: Zemax contains the active ingredient Lisinopril, which is formally classified as an Angiotensin-Converting Enzyme (ACE) Inhibitor. This means it works by targeting the ACE enzyme in the body to promote the widening of blood vessels (vasodilation) and reduce blood pressure. This specific mechanism is what defines its action compared to other classes of blood pressure medication.


Q: Is it common to feel tired when you first start Zemax?

A: Official documents from regulatory agencies list fatigue, or feeling tired, as a common adverse effect associated with this medication. This indicates that it is a frequently observed effect reported in clinical data.


Q: Is Zemax considered safe for long-term use?

A: The active ingredient in Zemax is generally prescribed for the long-term management of chronic conditions like high blood pressure and heart failure. Studies indicate that the medication's blood pressure-lowering effects are maintained during long-term therapy.


Q: Does Zemax interact with common vitamins or supplements?

A: Regulatory warnings specify caution with supplements or salt substitutes that contain potassium, as this medication is associated with an increased risk of elevated potassium levels in the blood. Other general vitamins are not typically listed as a direct interaction.


Q: Can Zemax affect my ability to drive or operate machinery?

A: Because this medication can cause side effects such as dizziness, lightheadedness, or feeling faint (hypotension), official warnings advise that caution should be exercised when driving or operating machinery until an individual is aware of how the medicine affects them.


Q: Can elderly patients use Zemax without special monitoring?

A: Official documents note that older patients tend to have higher concentrations of the active ingredient in their blood compared to younger patients, due to reduced clearance. Due to this difference, official documents indicate a lower starting dose may be used for elderly patients.


Q: How does Zemax get broken down in the body?

A: Regulatory information indicates that the active ingredient in Zemax is not metabolized or broken down by the body's enzyme systems. Instead, it is eliminated, unchanged, primarily through the kidneys in the urine.


Q: Does Zemax interact with pain relievers like ibuprofen or acetaminophen?

A: Co-administration with Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as ibuprofen, may increase the risk of renal (kidney) function deterioration. Official documents do not typically describe a direct, clinically significant interaction with acetaminophen.


Q: How quickly does Zemax usually start to work?

A: An effect on blood pressure has been observed in studies within 24 hours of dosing. Peak levels of the active ingredient in the blood are typically reached within about seven hours.


Q: Is it true that Zemax has a generic version available?

A: The active ingredient in this medication is Lisinopril, which is classified as the generic form of the compound. It is available under its generic name.


Q: Are there any specific lifestyle changes recommended when taking Zemax?

A: Regulatory documents advise caution with potassium intake; avoiding moderately high potassium dietary intake and potassium-containing salt substitutes is consistent with official warnings due to the risk of elevated potassium levels.


Q: Can I take Zemax if I occasionally drink alcohol?

A: Alcohol consumption may interact with this medicine. This effect may result in a greater drop in blood pressure, potentially leading to dizziness, lightheadedness, or fainting.


Q: Will Zemax still work if I stop taking it for a few days?

A: Regulatory study data show that abrupt discontinuation was not associated with a rapid return to significantly higher blood pressure levels compared to pretreatment levels.


Q: Is Zemax known to cause weight gain or loss?

A: Weight change is not listed in official documents as a common side effect of this medication. However, sudden or unexplained weight gain is noted in the warnings as a possible sign of fluid retention or angioedema (swelling), which are documented serious adverse events.


Q: Do many people experience a rash while taking Zemax?

A: Rash is reported in official documents as a potential adverse effect. A more serious, but rare, reaction is angioedema, which involves swelling and requires immediate attention.


Q: Is there any evidence that Zemax stops working over time?

A: Clinical evidence indicates that the blood pressure-lowering effects of the active ingredient are maintained during long-term use. The medication is prescribed for chronic, ongoing management.


Q: Can Zemax affect the results of blood tests?

A: Yes, the medication is known to affect the results of certain blood tests. It can lead to an increase in potassium levels in the blood, and it can also increase levels of Lithium if that medication is taken concurrently.


Q: What if I'm already taking a different prescription medication—is Zemax still an option?

A: The official documentation provides a clear interaction profile, listing several medicines that are contraindicated or require caution when combined with Zemax. The decision requires review against the current interaction list.


Q: Is Zemax a habit-forming or addictive medication?

A: No, this medication is not classified as a controlled substance by regulatory authorities. It is not described in official information as being habit-forming or addictive.


Q: How long after starting Zemax should I expect to see the full benefit?

A: Official regulatory data indicates that achieving the optimal blood pressure-lowering benefit may take between two to four weeks of consistent therapy.


Q: Are the side effects of Zemax usually temporary?

A: Many common initial side effects, such as dizziness or headache, are often transient. However, serious reactions such as the documented cough or angioedema are often persistent and may not resolve without adjustment.


Q: Where can I find the official patient information leaflet (PIL) for Zemax?

A: The official Patient Information, including the Prescribing Information and Medication Guide, is published by regulatory bodies. You can find this authoritative drug label information on government websites, such as the DailyMed service run by the National Institutes of Health (NIH).


Q: Can Zemax be split or crushed, or must it be swallowed whole?

A: The medication is supplied as an oral tablet. Unless official instructions explicitly state that the tablets can be split or crushed, they are typically designed to be swallowed whole.


Q: Why is my doctor asking me to monitor my symptoms while on Zemax?

A: Monitoring is typically associated with the risk of certain documented side effects and warnings listed in the official product information. This includes watching for signs of low blood pressure (hypotension), changes in kidney function, and the potential for swelling (angioedema).


Q: Is it normal to feel a change in appetite after starting Zemax?

A: A loss of appetite is listed as a potential, though not common, side effect in the official consumer information documents for this medication.

How should Zemax be stored and disposed of?

How to Store and Dispose of Zemax (Lisinopril) Tablets

The official storage guidelines for Zemax tablets focus on maintaining product stability and ensuring safety.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, 20 C to 25 C (68 F to 77 F).
Protection Keep the tablets in the original container, tightly closed, to protect them from moisture and excessive heat.
Prohibited The product must not be exposed to freezing temperatures or stored in damp areas.
Child Safety Store the medication out of the sight and reach of children.

Disposal Instructions

To dispose of any unused or expired Zemax, you must follow the instructions detailed by local authorities. Unused tablets and waste materials should be disposed of in accordance with local regulations, typically by using approved drug take-back or collection programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Zemax found in:

A-Z Index: